tetano
Editor, Senior Moderator
NEJM Evid
. 2025 Dec 17:EVIDpha2500069.
doi: 10.1056/EVIDpha2500069. Online ahead of print. Influenza Virus Characteristics in Department of Defense Populations, 2024-2025
Anthony C Fries[SUP] 1 [/SUP], Kayla M Septer[SUP] 2 3 [/SUP], William E Gruner[SUP] 1 4 [/SUP], Zhaodong Liang[SUP] 2 [/SUP], Angelia A Eick-Cost[SUP] 5 [/SUP], Jeffrey W Thervil[SUP] 1 6 [/SUP], Dara A Russell[SUP] 5 [/SUP], Daniel F Ewing[SUP] 2 [/SUP], Laurie S Demarcus[SUP] 1 6 [/SUP], Appavu K Sundaram[SUP] 2 [/SUP], Tamara R Hartless[SUP] 1 6 [/SUP], Bismark Kwaah[SUP] 1 6 [/SUP], Deanna M Muehleman[SUP] 1 4 [/SUP], Jimmaline Hardy[SUP] 1 4 [/SUP], M Shayne Gallaway[SUP] 5 [/SUP]
Affiliations
AbstractThe influenza virus constantly evolves through antigenic shift and drift, requiring annual review to inform the development of seasonal influenza vaccines. The Department of Defense Global Respiratory Pathogen Surveillance Program and Global Emerging Infections Surveillance program-funded partner laboratories perform routine respiratory pathogen surveillance across a wide-reaching global network of service members and their beneficiaries, U.S. civilians, and some foreign national populations. This report describes the influenza viruses circulating during the 2024-2025 influenza season.
. 2025 Dec 17:EVIDpha2500069.
doi: 10.1056/EVIDpha2500069. Online ahead of print. Influenza Virus Characteristics in Department of Defense Populations, 2024-2025
Anthony C Fries[SUP] 1 [/SUP], Kayla M Septer[SUP] 2 3 [/SUP], William E Gruner[SUP] 1 4 [/SUP], Zhaodong Liang[SUP] 2 [/SUP], Angelia A Eick-Cost[SUP] 5 [/SUP], Jeffrey W Thervil[SUP] 1 6 [/SUP], Dara A Russell[SUP] 5 [/SUP], Daniel F Ewing[SUP] 2 [/SUP], Laurie S Demarcus[SUP] 1 6 [/SUP], Appavu K Sundaram[SUP] 2 [/SUP], Tamara R Hartless[SUP] 1 6 [/SUP], Bismark Kwaah[SUP] 1 6 [/SUP], Deanna M Muehleman[SUP] 1 4 [/SUP], Jimmaline Hardy[SUP] 1 4 [/SUP], M Shayne Gallaway[SUP] 5 [/SUP]
Affiliations
- PMID: 41405965
- DOI: 10.1056/EVIDpha2500069
AbstractThe influenza virus constantly evolves through antigenic shift and drift, requiring annual review to inform the development of seasonal influenza vaccines. The Department of Defense Global Respiratory Pathogen Surveillance Program and Global Emerging Infections Surveillance program-funded partner laboratories perform routine respiratory pathogen surveillance across a wide-reaching global network of service members and their beneficiaries, U.S. civilians, and some foreign national populations. This report describes the influenza viruses circulating during the 2024-2025 influenza season.